Didactics-Quality indicators and training for cytoreductive surgery_Asima

Quality indicators and training for cytoreductive surgery_Asima_MAR 2022

Video Transcription

Video Summary

In this video, the speaker discusses the importance of quality indicators and training for cytoreductive surgery, specifically in the context of ovarian cancer. They emphasize that ovarian cancer is expected to rise by 50% in the next 20 years, with increasing numbers seen in clinics every day. The speaker highlights that surgery, along with BRCA, HRD, and PARP inhibitors, has contributed to improved survival rates. They argue that a good biology does not compensate for poor quality surgery and that improved quality reduces costs in the long run. The speaker also stresses the need for a dedicated team and specialized service for cytoreductive surgery, as well as adherence to guidelines and proper documentation. They share their own experiences and research findings, discussing topics such as the debate between neoadjuvant or primary surgery, resectability, and the importance of interdisciplinary collaboration. The speaker concludes by highlighting the significance of training, quality improvement programs, and the need for continued research and clinical trials in order to improve outcomes for ovarian cancer patients.

Keywords

cytoreductive surgery

ovarian cancer

improved survival rates

dedicated team

interdisciplinary collaboration

clinical trials